Prosecution Insights
Last updated: August 18, 2026

Examiner: ALAM, AYAAN A

Tech Center 1600 • Art Units: 1611

This examiner grants 38% of resolved cases

Performance Statistics

37.6%
Allow Rate
-22.4% vs TC avg
211
Total Applications
+33.9%
Interview Lift
1200
Avg Prosecution Days
Based on 149 resolved cases, 2023–2026

Rejection Statute Breakdown

2.7%
§101 Eligibility
11.1%
§102 Novelty
54.6%
§103 Obviousness
22.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18753538 COMPRESSED TABLETS Final Rejection DSM IP Assets B.V.
17961142 SULFATE FREE PERSONAL CLEANSING COMPOSITION COMPRISING LOW INORGANIC SALT AND HYDROXAMIC ACID OR HYDROXAMIC ACID DERIVATIVES Non-Final OA The Procter & Gamble Company
17618390 OSTEOINDUCTIVE MODIFIED GELATIN HYDROGELS AND METHODS OF MAKING AND USING THE SAME Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17592514 COMPOSITION FOR AEROSOL COSMETICS, AND AEROSOL COSMETICS Non-Final OA SHIN-ETSU CHEMICAL CO., LTD.
17763909 NOVEL COMPOSITIONS AND METHODS FOR BONE GRAFTS AND FUSIONS Final Rejection The Johns Hopkins University
18693848 FOAMING COMPOSITION Non-Final OA L'OREAL
18543157 COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND ADDITIONAL ORGANIC UV FILTER(S) Final Rejection L'OREAL
17789501 METAL OXIDE PARTICLES COATED WITH A RARE-EARTH OXIDE AND PROCESS FOR PREPARING SAME BY FLAME SPRAY PYROLYSIS Non-Final OA L'OREAL
17757174 SUN CARE COMPOSITION Final Rejection L'OREAL
16916961 WATER-IN-OIL EMULSIONS CONTAINING LOW HLB SURFACTANT, SILICONE GUM AND SILOXYSILICATE RESIN Final Rejection L'ORÉAL
18695471 LIPID NANOPARTICLE (LNP) COMPOSITIONS AND METHODS OF USE THEREOF Non-Final OA The Trustees Of The University of Pennsylvania
18577138 METHOD FOR DYEING KERATINOUS MATERIAL, INCLUDING THE APPLICATION OF AN ORGANOSILICON COMPOUND, POLYETHYLENE GLYCOLS, A DYEING COMPOUND, AND AN AFTERTREATMENT AGENT Final Rejection HENKEL AG & CO. KGAA
18274020 COSMETIC HAVING TITANIUM DIOXIDE IN THE AQUEOUS PHASE Final Rejection BEIERSDORF AG
18035969 METAL-ORGANIC FRAMEWORK MEDIATED MACROMOLECULE DELIVERY SYSTEM Non-Final OA The Brigham and Women's Hospital, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month